GB0610949D0 - Method - Google Patents

Method

Info

Publication number
GB0610949D0
GB0610949D0 GB0610949A GB0610949A GB0610949D0 GB 0610949 D0 GB0610949 D0 GB 0610949D0 GB 0610949 A GB0610949 A GB 0610949A GB 0610949 A GB0610949 A GB 0610949A GB 0610949 D0 GB0610949 D0 GB 0610949D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0610949A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0610949A priority Critical patent/GB0610949D0/en
Publication of GB0610949D0 publication Critical patent/GB0610949D0/en
Priority to EP07725789A priority patent/EP2032719A2/en
Priority to CNA2007800288375A priority patent/CN101501218A/en
Priority to JP2009512510A priority patent/JP2009538607A/en
Priority to EP10159376.2A priority patent/EP2258874B1/en
Priority to EP11162324A priority patent/EP2390353A1/en
Priority to AU2007256383A priority patent/AU2007256383B2/en
Priority to EP11163726A priority patent/EP2390369A1/en
Priority to EP11163716A priority patent/EP2390364A1/en
Priority to EP11163261A priority patent/EP2390358A1/en
Priority to EP11163713A priority patent/EP2390363A1/en
Priority to EP11162323A priority patent/EP2392672A1/en
Priority to EP11162320A priority patent/EP2392671A1/en
Priority to CA002653949A priority patent/CA2653949A1/en
Priority to EP11163252A priority patent/EP2390357A1/en
Priority to US12/303,213 priority patent/US20100021424A1/en
Priority to ARP070102352A priority patent/AR061136A1/en
Priority to EP11163264A priority patent/EP2390360A1/en
Priority to MX2008015372A priority patent/MX2008015372A/en
Priority to BRPI0712497-0A priority patent/BRPI0712497A2/en
Priority to EP11162329A priority patent/EP2392673A1/en
Priority to EP11163722A priority patent/EP2390368A1/en
Priority to CL200701571A priority patent/CL2007001571A1/en
Priority to EP11163271A priority patent/EP2390361A1/en
Priority to PE2007000676A priority patent/PE20080742A1/en
Priority to EP11162326A priority patent/EP2390355A1/en
Priority to ES10159376.2T priority patent/ES2539042T3/en
Priority to TW096119645A priority patent/TW200817680A/en
Priority to EP11163717A priority patent/EP2390365A1/en
Priority to EP11163719A priority patent/EP2390366A1/en
Priority to EP11163263A priority patent/EP2390359A1/en
Priority to EP11162325A priority patent/EP2390354A1/en
Priority to KR1020087031950A priority patent/KR20090017655A/en
Priority to EP11163720A priority patent/EP2390367A1/en
Priority to EP11163277A priority patent/EP2390362A1/en
Priority to EA200802242A priority patent/EA200802242A1/en
Priority to PCT/EP2007/004915 priority patent/WO2007140958A2/en
Priority to EP11163268A priority patent/EP2392675A1/en
Priority to EP11162327A priority patent/EP2390356A1/en
Ceased legal-status Critical Current

Links

GB0610949A 2006-06-02 2006-06-02 Method Ceased GB0610949D0 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
GB0610949A GB0610949D0 (en) 2006-06-02 2006-06-02 Method
BRPI0712497-0A BRPI0712497A2 (en) 2006-06-02 2007-05-31 gene profile, use of a profile, method for identifying a profile, uses of a probe and microarray kit for identifying differential expression of at least one immune activating gene product, microarray, diagnostic kit, and, method for treating a patient, and for inducing a distinguished responder gene profile in a nonresponder.
MX2008015372A MX2008015372A (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy.
EP11162329A EP2392673A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the FOXP3 gene
JP2009512510A JP2009538607A (en) 2006-06-02 2007-05-31 How to identify whether a patient is a responder to immunotherapy
EP10159376.2A EP2258874B1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy
EP11162324A EP2390353A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the CD69 gene.
AU2007256383A AU2007256383B2 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy
EP11163726A EP2390369A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the GZMB gene
EP11163716A EP2390364A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differnetial expression of the PRKCQ gene
EP11163261A EP2390358A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the GZMK gene
EP11163713A EP2390363A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the PRF1 gene
EP11162323A EP2392672A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the CD52 gene
EP11162320A EP2392671A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the CD3D gene
CA002653949A CA2653949A1 (en) 2006-06-02 2007-05-31 Method
EP11163722A EP2390368A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the CXCR3 gene
US12/303,213 US20100021424A1 (en) 2006-06-02 2007-05-31 Method For Identifying Whether A Patient Will Be Responder or Not to Immunotherapy
ARP070102352A AR061136A1 (en) 2006-06-02 2007-05-31 PROCESS
EP11163264A EP2390360A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the IDO1 gene
EP07725789A EP2032719A2 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy
EP11162327A EP2390356A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the FASLG gene
EP11163277A EP2390362A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differnetial expression of the IRF1 gene
EP11163252A EP2390357A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the GPR171 gene
CL200701571A CL2007001571A1 (en) 2006-06-02 2007-05-31 GENE INDICATIVE PROFILE OF PROBABILITY INCREASED THAT A PATIENT RESPONDS OR NOT TO IMMUNOTHERAPY; USE OF SUCH PROFILE; PROFILE IDENTIFICATION PROCEDURE; USE OF PROBE TO IDENTIFY DIFFERENTIAL EXPRESSION OF AT LEAST ONE ACT GEN
EP11163271A EP2390361A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the IL7R gene
PE2007000676A PE20080742A1 (en) 2006-06-02 2007-05-31 GENE PROFILE AND IDENTIFICATION PROCEDURE
EP11162326A EP2390355A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be resopnder or not to immunotherapy based on the differential expression of the CXCL10 gene
ES10159376.2T ES2539042T3 (en) 2006-06-02 2007-05-31 Identification procedure of whether a patient will respond to immunotherapy or not
TW096119645A TW200817680A (en) 2006-06-02 2007-05-31 Method
EP11163717A EP2390365A1 (en) 2006-06-02 2007-05-31 Method for identifiying whether a patient will be responder or not to immunotherapy based on the differential expression of the STAT4 gene
EP11163719A EP2390366A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the TRAT1 gene
EP11163263A EP2390359A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the ICOS gene
EP11162325A EP2390354A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the CD8A gene.
KR1020087031950A KR20090017655A (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy
EP11163720A EP2390367A1 (en) 2006-06-02 2007-05-31 Methods for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the UBD gene
CNA2007800288375A CN101501218A (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy
EA200802242A EA200802242A1 (en) 2006-06-02 2007-05-31 METHOD FOR DETERMINING THAT, WILL BE OR WILL NOT BE A PATIENT BY RESPONDER FOR IMMUNOTHERAPY
PCT/EP2007/004915 WO2007140958A2 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy
EP11163268A EP2392675A1 (en) 2006-06-02 2007-05-31 Method for identifying whether a patient will be responder or not to immunotherapy based on the differential expression of the IFNG gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0610949A GB0610949D0 (en) 2006-06-02 2006-06-02 Method

Publications (1)

Publication Number Publication Date
GB0610949D0 true GB0610949D0 (en) 2006-07-12

Family

ID=36694866

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0610949A Ceased GB0610949D0 (en) 2006-06-02 2006-06-02 Method

Country Status (2)

Country Link
CN (1) CN101501218A (en)
GB (1) GB0610949D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016005947B3 (en) * 2016-05-16 2017-06-08 Dimo Dietrich A method for estimating the prognosis and predicting the response to immunotherapy of patients with malignant diseases
GB201611738D0 (en) * 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease

Also Published As

Publication number Publication date
CN101501218A (en) 2009-08-05

Similar Documents

Publication Publication Date Title
GB0601961D0 (en) Method
GB0603081D0 (en) Method
GB0607317D0 (en) Method
GB0606147D0 (en) Method
GB0618001D0 (en) Method
ZA200807046B (en) Beer-brewing method
GB0605323D0 (en) Method
GB0603008D0 (en) Method
GB0604018D0 (en) Method
GB0601699D0 (en) Method
GB0602986D0 (en) Method
GB0618046D0 (en) Method
GB0622580D0 (en) Method
GB0606954D0 (en) Method
GB0625782D0 (en) Method
GB0618656D0 (en) Method
GB0612342D0 (en) Method
GB0612014D0 (en) Method
GB0610949D0 (en) Method
GB0617274D0 (en) Method
GB0610338D0 (en) Method
GB0609901D0 (en) Method
GB0602830D0 (en) Method
GB0620284D0 (en) Novel method
GB0618700D0 (en) Novel method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)